X0203 3 2010-06-29 0 0001341293 Neogenix Oncology Inc None 0001495539 Arlen Myron 445 NORTHERN BOULEVARD, SUITE 24 GREAT NECK NY 11021 1 1 1 0 Director of Medical Affairs Common Stock 3932560 D Common Stock 790 I By spouse Stock Option (Right to Buy) 8 2009-05-04 2014-05-04 Common Stock 500000 D Stock Option (Right to Buy) 6 2009-01-19 2014-01-19 Common Stock 500000 D Stock Option (Right to Buy) 5 2007-04-21 2012-04-21 Common Stock 300000 D Stock Option (Right to Buy) 5 2007-04-21 2012-04-21 Common Stock 100000 I By spouse Warrant (Right to Buy) 6 2009-12-01 Common Stock 2089 D Warrant (Right to Buy) 6 2009-12-01 Common Stock 647 I By spouse The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These warrants expire upon the earliest to occur of (i) December 31, 2013; (ii) the completion of an IPO (an underwritten public offering of shares of the Common Stock of the Company under the Securities Act); and (iii) an Exit Event (a merger or consolidation of the Company that results in a change of control or the sale, license or lease of all or substantially all of the assets of the Company to an unaffiliated third party). Exhibit List Exhibit 24: Power of Attorney /s/ Daniel Scher, attorney-in-fact 2010-06-30